6.68
price up icon1.75%   0.11
after-market Handel nachbörslich: 6.54 -0.14 -2.10%
loading
Schlusskurs vom Vortag:
$6.57
Offen:
$6.49
24-Stunden-Volumen:
157.20K
Relative Volume:
0.40
Marktkapitalisierung:
$446.84M
Einnahmen:
$555.06M
Nettoeinkommen (Verlust:
$-39.48M
KGV:
-11.13
EPS:
-0.6
Netto-Cashflow:
$29.05M
1W Leistung:
+0.53%
1M Leistung:
-7.54%
6M Leistung:
-15.59%
1J Leistung:
-46.82%
1-Tages-Spanne:
Value
$6.46
$6.72
1-Wochen-Bereich:
Value
$6.37
$6.83
52-Wochen-Spanne:
Value
$5.81
$14.38

Bioventus Inc Stock (BVS) Company Profile

Name
Firmenname
Bioventus Inc
Name
Telefon
(919) 474-6700
Name
Adresse
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Name
Mitarbeiter
950
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-11
Name
Neueste SEC-Einreichungen
Name
BVS's Discussions on Twitter

Vergleichen Sie BVS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
BVS
Bioventus Inc
6.68 435.47M 555.06M -39.48M 29.05M -0.60
Medical Devices icon
ABT
Abbott Laboratories
133.26 228.66B 43.11B 13.94B 6.78B 7.9963
Medical Devices icon
BSX
Boston Scientific Corp
96.24 140.69B 18.49B 2.50B 3.49B 1.6801
Medical Devices icon
SYK
Stryker Corp
369.88 139.51B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
96.53 122.60B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
73.35 42.83B 5.69B 1.41B 577.90M 6.9828

Bioventus Inc Stock (BVS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-07 Eingeleitet Cantor Fitzgerald Overweight
2024-12-17 Hochstufung JP Morgan Underweight → Neutral
2023-12-07 Hochstufung Canaccord Genuity Hold → Buy
2023-08-09 Hochstufung Craig Hallum Hold → Buy
2022-11-22 Herabstufung Craig Hallum Buy → Hold
2022-11-09 Herabstufung Canaccord Genuity Buy → Hold
2022-11-09 Herabstufung JP Morgan Overweight → Underweight
2022-03-15 Eingeleitet Craig Hallum Buy
2021-11-15 Fortgesetzt Morgan Stanley Overweight
2021-11-10 Fortgesetzt JP Morgan Overweight
2021-07-01 Herabstufung Goldman Buy → Neutral
2021-03-08 Eingeleitet Canaccord Genuity Buy
2021-03-08 Eingeleitet Goldman Buy
2021-03-08 Eingeleitet JP Morgan Overweight
2021-03-08 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Bioventus Inc Aktie (BVS) Neueste Nachrichten

pulisher
03:11 AM

Bioventus Inc. stock chart pattern explainedProduct Launch & Safe Entry Trade Signal Reports - newser.com

03:11 AM
pulisher
Oct 12, 2025

Head-To-Head Comparison: Vyome (NASDAQ:HIND) vs. Bioventus (NASDAQ:BVS) - Defense World

Oct 12, 2025
pulisher
Oct 12, 2025

Head-To-Head Survey: Bioventus (NASDAQ:BVS) & Shoulder Innovations (NYSE:SI) - Defense World

Oct 12, 2025
pulisher
Oct 11, 2025

Analyzing TranS1 (OTCMKTS:BAXSQ) and Bioventus (NASDAQ:BVS) - Defense World

Oct 11, 2025
pulisher
Oct 10, 2025

Analyzing recovery setups for Bioventus Inc. investorsM&A Rumor & Weekly High Conviction Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Bioventus Inc. stock retracement – recovery analysisWeekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Bioventus (NASDAQ:BVS) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

What technical models suggest about Bioventus Inc.’s comebackJuly 2025 Update & Expert Curated Trade Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Full technical analysis of Bioventus Inc. stockMarket Performance Recap & Real-Time Volume Trigger Notifications - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Is Bioventus Inc a good long term investmentSwing Trading Ideas & Rapid Capital Gain - earlytimes.in

Oct 08, 2025
pulisher
Oct 07, 2025

290,700 Shares in Bioventus Inc. $BVS Acquired by Knights of Columbus Asset Advisors LLC - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

Multi factor analysis applied to Bioventus Inc.Earnings Summary Report & Breakout Confirmation Trade Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Volatility clustering patterns for Bioventus Inc.Quarterly Portfolio Summary & Daily Oversold Stock Bounce Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can Bioventus Inc. hit a new high this monthPortfolio Value Report & Technical Pattern Alert System - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How Bioventus Inc. stock benefits from strong dollarPortfolio Update Summary & Reliable Intraday Trade Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Using Bollinger Bands to evaluate Bioventus Inc.Trade Analysis Summary & Free Fast Gain Swing Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 02, 2025

Forecasting Bioventus Inc. price range with options data2025 Breakouts & Breakdowns & Intraday High Probability Alerts - newser.com

Oct 02, 2025
pulisher
Oct 01, 2025

Bioventus Inc Stock Analysis and ForecastBear Market Strategies & In-Depth Analyst Ratings Explained Simply - earlytimes.in

Oct 01, 2025
pulisher
Oct 01, 2025

What drives Bioventus Inc stock priceBreakout Stock Watch & Small Investment Portfolio Growth - earlytimes.in

Oct 01, 2025
pulisher
Sep 30, 2025

PetVivo (NASDAQ:PETV) versus Bioventus (NYSE:BVS) Head-To-Head Comparison - Defense World

Sep 30, 2025
pulisher
Sep 28, 2025

Comparing Bioventus Inc. in custom built stock radarsProduct Launch & Fast Entry Momentum Alerts - newser.com

Sep 28, 2025
pulisher
Sep 27, 2025

Comparing Bioventus (NYSE:BVS) and Retractable Technologies (NYSE:RVP) - Defense World

Sep 27, 2025
pulisher
Sep 27, 2025

Orthobiologics Market May See a Big Move | Major Giants Medtronic, Zimmer Biomet, Bioventus - newstrail.com

Sep 27, 2025
pulisher
Sep 26, 2025

Is Bioventus Inc. building a consolidation baseTreasury Yields & Weekly Chart Analysis and Trade Guides - newser.com

Sep 26, 2025
pulisher
Sep 26, 2025

Bioventus (NYSE:BVS) Shares Gap DownHere's What Happened - MarketBeat

Sep 26, 2025
pulisher
Sep 26, 2025

Bioventus Inc. stock daily chart insightsBull Run & Technical Pattern Recognition Alerts - newser.com

Sep 26, 2025
pulisher
Sep 25, 2025

Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating - 富途牛牛

Sep 25, 2025
pulisher
Sep 24, 2025

Should You Be Worried About Bioventus Inc.'s (NASDAQ:BVS) 1.3% Return On Equity? - Yahoo Finance

Sep 24, 2025

Finanzdaten der Bioventus Inc-Aktie (BVS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$318.39
price up icon 1.22%
medical_devices STE
$237.73
price up icon 1.00%
$66.21
price up icon 1.55%
medical_devices PHG
$27.16
price down icon 1.22%
$72.34
price up icon 0.70%
medical_devices EW
$73.35
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):